Key result
Enhanced recovery after surgery (ERAS) protocols require more specific evidence for implementation in ovarian cancer patients due to the distinct characteristics of the disease.
Why the study?
Limitations exist in implementing ERAS guidelines in ovarian cancer patients due to the distinct characteristics of the disease, requiring specific evidence assessment.
This review highlights the limitations of implementing general gynecologic ERAS guidelines in ovarian cancer patients and emphasizes the need for disease-specific evidence.
Urges caution applying general ERAS to ovarian cancer; leaves open need for disease-specific protocols.
The enhanced recovery after surgery (ERAS) refers to multimodal interventions to reduce the length of hospital stay and complications at various steps of perioperative care. It was first developed in colorectal surgery and later embraced by other surgical disciplines including gynecologic oncology. The ERAS Society recently published guidelines for gynecologic cancer surgeries to enhance patient recovery. However, limitations exist in the implementation of the guidelines in ovarian cancer patients due to the distinct characteristics of the disease. In the present review, we discuss the results that have been published in the literature to date regarding the ERAS protocols in ovarian cancer patients, and explain why more evidence needs to be specifically assessed in this type of malignancy among other gynecologic cancers.
No takes yet. Share an insight, caveat, or question.
Noh et al. (2021) conducted a review in Ovarian cancer. Enhanced recovery after surgery (ERAS) protocols was evaluated. Enhanced recovery after surgery (ERAS) protocols require more specific evidence for implementation in ovarian cancer patients due to the distinct characteristics of the disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: